Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
- Status
- TERMINATED
- Phase
- PHASE3
A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Double Cord Versus Haploidentical (BMT CTN 1101)
- Status
- COMPLETED
- Phase
- PHASE3
Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Velcade, Nipent, Rituxan (VNR) in Subjects With Relapsed Follicular, Marginal Zone, and Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)
- Status
- COMPLETED
- Phase
- PHASE3
Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)
- Status
- TERMINATED
- Phase
- PHASE1
Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Imexon for Relapsed Follicular and Aggressive Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2